256
Participants
Start Date
October 6, 2015
Primary Completion Date
October 1, 2026
Study Completion Date
October 1, 2026
Methylprednisolone
IPS cohort only
Oxygen Therapy
Receive high flow oxygen therapy
Positive Air Pressure Device
Undergo NIPPV
RECRUITING
M D Anderson Cancer Center, Houston
M.D. Anderson Cancer Center
OTHER